Table Table 1.
Clinicopathologic characteristics of study series.
| Number (n = 20) | Percentage | Median | ||
|---|---|---|---|---|
| Gender | Female | 13 | 65 | – |
| Male | 7 | 35 | – | |
| Differentiation | Well | 0 | 0 | – |
| Moderate | 11 | 55 | – | |
| Poor | 8 | 40 | – | |
| Undifferentiated | 1 | 5 | – | |
| pT | T1 | 1 | 5 | – |
| T2 | 0 | 0 | – | |
| T3 | 18 | 90 | – | |
| T4 | 1 | 5 | – | |
| N | N0 | 6 | 30 | – |
| N1 | 14 | 70 | – | |
| M | M0 | 19 | 95 | – |
| M1 | 1 | 5 | – | |
| R | R0 | 8 | 40 | – |
| R1 | 12 | 60 | – | |
| Vessel infiltration | No | 9 | 45 | – |
| Yes | 11 | 55 | – | |
| Perineural infiltration | No | 1 | 5 | – |
| Yes | 19 | 95 | – | |
| KRAS codons 12/13 | Mutated | 15 | 75 | – |
| Wild type | 5 | 25 | – | |
| Age (in years) | – | – | 69.00 | |
| Disease free survival (DFS) (in months) | – | – | 17.34 | |
| Overall survival (OS) (in months) | – | – | 21.25 | |